MX9204110A - Derivados del acido quinolonacarboxilico y procedimiento para su preparacion. - Google Patents

Derivados del acido quinolonacarboxilico y procedimiento para su preparacion.

Info

Publication number
MX9204110A
MX9204110A MX9204110A MX9204110A MX9204110A MX 9204110 A MX9204110 A MX 9204110A MX 9204110 A MX9204110 A MX 9204110A MX 9204110 A MX9204110 A MX 9204110A MX 9204110 A MX9204110 A MX 9204110A
Authority
MX
Mexico
Prior art keywords
quinolonacarboxilico
derivatives
procedure
preparation
acid
Prior art date
Application number
MX9204110A
Other languages
English (en)
Spanish (es)
Inventor
Uwe Petersen
Thomas Himmler
Thomas Schenke
Andreas Krebs
Klaus Grohe
Klaus-Dieter Bremm
Karl Georg Metzger
Rainer Endermann
Hans-Joachim Zeiler
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MX9204110A publication Critical patent/MX9204110A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Paints Or Removers (AREA)
MX9204110A 1991-07-19 1992-07-14 Derivados del acido quinolonacarboxilico y procedimiento para su preparacion. MX9204110A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4123918A DE4123918A1 (de) 1991-07-19 1991-07-19 8-vinyl- und 8-ethinyl-chinoloncarbonsaeuren

Publications (1)

Publication Number Publication Date
MX9204110A true MX9204110A (es) 1993-08-01

Family

ID=6436512

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9204110A MX9204110A (es) 1991-07-19 1992-07-14 Derivados del acido quinolonacarboxilico y procedimiento para su preparacion.

Country Status (22)

Country Link
EP (1) EP0523512B1 (enExample)
JP (1) JP3174405B2 (enExample)
KR (1) KR100240608B1 (enExample)
AT (1) ATE147733T1 (enExample)
AU (1) AU658901B2 (enExample)
CA (1) CA2073993A1 (enExample)
CZ (1) CZ282037B6 (enExample)
DE (2) DE4123918A1 (enExample)
DK (1) DK0523512T3 (enExample)
ES (1) ES2097835T3 (enExample)
FI (1) FI103043B1 (enExample)
GR (1) GR3022305T3 (enExample)
HU (1) HU219910B (enExample)
IE (1) IE80557B1 (enExample)
IL (1) IL102520A (enExample)
MX (1) MX9204110A (enExample)
NO (1) NO302886B1 (enExample)
PL (1) PL171910B1 (enExample)
RU (1) RU2077533C1 (enExample)
SK (1) SK219192A3 (enExample)
TW (1) TW201309B (enExample)
ZA (1) ZA925351B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4121214A1 (de) * 1991-06-27 1993-01-14 Bayer Ag 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
DE4230804A1 (de) * 1992-09-15 1994-03-17 Bayer Ag 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate
DE4303657A1 (de) * 1993-02-09 1994-08-11 Bayer Ag Neue Chinolon- und Naphthyridoncarbonsäurederivate
KR950018003A (ko) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 신규한 퀴놀론 유도체 및 그의 제조 방법
DE4418510A1 (de) * 1994-05-27 1995-11-30 Bayer Ag 1,9-überbrückte Thiazolol[3,4-a]chinolinderivate
DE4425659A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Neue N1-diverse 6-Fluor-8-difluormethoxy substituierte Chinoloncarbonsäuren
DE4427530A1 (de) * 1994-08-04 1996-02-08 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
RU2173318C2 (ru) * 1996-02-23 2001-09-10 Байер Акциенгезелльшафт 8-циан-1-циклопропил-7-(2,8-диазабицикло(4.3.0)-нонан-8-ил)-6-фтор-1,4-дигидро-4-оксо-3-хинолинкарбоновые кислоты, их производные и фармацевтическая композиция, обладающая антибактериальной активностью
DK0897919T3 (da) 1996-04-19 2004-09-27 Wakunaga Pharma Co Ltd Nye pyridoncarboxylsyrederivater eller salte deraf samt antibakterielle midler indeholdende disse som den aktive bestanddel
WO1998024781A1 (en) * 1996-12-04 1998-06-11 Daiichi Pharmaceutical Co., Ltd. Substituted aminomethylpyrrolidine derivatives
PT1015445E (pt) 1997-09-15 2009-05-14 Procter & Gamble Quinolonas antimicrobianas, suas composições e seus usos
KR101077755B1 (ko) 2003-09-10 2011-10-27 교린 세이야꾸 가부시키 가이샤 7-(4-치환-3-시클로프로필아미노메틸-1-피롤리디닐)퀴놀론카르본산 유도체
US7563805B2 (en) * 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
RU2420524C2 (ru) * 2005-05-19 2011-06-10 Дайити Санкио Компани, Лимитед Производные три- или тетра-замещенного-3-аминопирролидина
JP5073497B2 (ja) * 2005-09-28 2012-11-14 第一三共株式会社 テトラ置換−5−アザスピロ[2.4]へプタン誘導体の製法およびその光学活性中間体
BRPI0709220A2 (pt) 2006-03-28 2011-07-12 Procter & Gamble processo de acoplamento para preparo de intermediários de quinolona
SI2001862T1 (sl) 2006-03-28 2011-10-28 Warner Chilcott Co Llc Soli malatov in polimorfi (3S, 5S)-7-(3-amino-5-metil-piperidinil)-1-ciklopropil-1,4-dihidro-8-metoksi- 4-okso-3-kinolinkarboksline kisline
US8222407B2 (en) 2007-05-24 2012-07-17 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
EP3790874B1 (en) * 2018-05-09 2023-03-15 Bayer Animal Health GmbH Anthelmintic quinoline derivatives
RU2757741C1 (ru) * 2021-03-01 2021-10-21 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Производное ципрофлоксацина, обладающее антибактериальной активностью в отношении антибиотикоустойчивых штаммов микроорганизмов

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123536A (en) * 1977-12-14 1978-10-31 Warner-Lambert Company Dialkyl ({[3-(alkoxycarbonyl)-1,4-dihydro-4-oxo-8-quinolinyl]amino}methylene)propanedioates
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
JPS62215572A (ja) * 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
US5047538A (en) * 1990-04-12 1991-09-10 Warner-Lambert Company Quinolinecarboxylic acid antibacterial agents

Also Published As

Publication number Publication date
CA2073993A1 (en) 1993-01-20
GR3022305T3 (en) 1997-04-30
ATE147733T1 (de) 1997-02-15
EP0523512B1 (de) 1997-01-15
SK279221B6 (sk) 1998-08-05
ZA925351B (en) 1993-04-28
SK219192A3 (en) 1998-08-05
NO922639L (no) 1993-01-20
CZ282037B6 (cs) 1997-04-16
HU9202349D0 (en) 1992-10-28
FI103043B (fi) 1999-04-15
IE80557B1 (en) 1998-09-23
PL171910B1 (pl) 1997-06-30
IL102520A0 (en) 1993-01-14
FI103043B1 (fi) 1999-04-15
RU2077533C1 (ru) 1997-04-20
NO302886B1 (no) 1998-05-04
TW201309B (enExample) 1993-03-01
KR930002320A (ko) 1993-02-22
EP0523512A1 (de) 1993-01-20
DE4123918A1 (de) 1993-01-21
DE59207880D1 (de) 1997-02-27
DK0523512T3 (da) 1997-06-30
HUT61741A (en) 1993-03-01
PL295331A1 (en) 1993-07-12
JP3174405B2 (ja) 2001-06-11
IE922348A1 (en) 1993-01-27
KR100240608B1 (ko) 2000-03-02
AU658901B2 (en) 1995-05-04
NO922639D0 (no) 1992-07-03
FI923268L (fi) 1993-01-20
CZ219192A3 (en) 1993-02-17
AU1966392A (en) 1993-01-21
HU219910B (hu) 2001-09-28
FI923268A0 (fi) 1992-07-16
ES2097835T3 (es) 1997-04-16
IL102520A (en) 1997-07-13
JPH05262738A (ja) 1993-10-12

Similar Documents

Publication Publication Date Title
MX9207604A (es) Derivados del acido quinolon-carboxilico y del acido naftiridon-carboxilico y procedimiento para su fabricacion.
MX9204110A (es) Derivados del acido quinolonacarboxilico y procedimiento para su preparacion.
ES2111092T3 (es) Derivados de acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos.
ES542320A0 (es) Un procedimiento para la preparacion de derivados de la 2 pirimidinil 1 piperazina
ES557359A0 (es) Un procedimiento para preparar derivados de piperazina
MX9400341A (es) Derivados de los acidos quinolon- y naftiridon-carboxilicos, procedimiento para su obtencion y agentes antibacterianos y aditivos para piensos que los contienen.
MX9306023A (es) Acidos quinoloncarboxilicos y procedimiento para su obtencion.
ES454964A1 (es) Un procedimiento para la preparacion de acido 7-d-(-)-alfa- amino-alfa-(p-hidroxifenilacetamido) desacetoxicefalospora- nico, hidrato o sales farmaceuticamente aceptables del mis- mo.
IT7949662A0 (it) Procedimento per la produzione di acido tereftalico da metiltereftala to come prodotto intermedio
ES2045009T3 (es) El acido taurohyodesoxicolico para la terapia de calculosis del tracto biliar y de la dispepsia biliar.
IT1154024B (it) Derivati pridinici e procedimento per la loro produzione
AR226917A1 (es) Procedimiento para la produccion de derivados del acido quinolincarboxilico
MX9205435A (es) Derivados del acido imidazolil-propenico substituidos y procedimiento para su fabricacion.
ES2007328A4 (es) Derivados de dihidropiridazinona, proceso de fabricacion y medicamentos con sus combinaciones
ES2065737T3 (es) Derivados de acido mandelico substituidos como inhibidores de 5-lipoxigenasa.
ES424017A1 (es) Procedimiento para la produccion de esteres del acido fos- forico.
ES540213A0 (es) Procedimiento para la obtencion de esteres del acido salici-lico, de efecto perfumante
ES537480A0 (es) Procedimiento para la fabricacion de la reductasa del acido 2, 5-diceto-d-gluconico
ES2068497T3 (es) Derivados de urea, su produccion, y composiciones farmaceuticas que los contienen.
ES555612A0 (es) Procedimiento para la produccion de derivados del acido 7-amino-3-alcoximetil-3-cefem-4-carboxilico
ES523664A0 (es) Procedimiento para la preparacion de nuevos derivados del acido quinolicincarboxilico.
MX158754A (es) Procedimiento para la preparacion de compuestos derivados y sus esteroisomeros,del acido 16-fenoxi-y 16 fenoxi;-substituido-prostatrienoico
AU544615B2 (en) Prostaglandin derivatives
GT199200063A (es) Procedimiento de produccion de derivados del acido quinolon carboxilico y del acido naftiridon carboxilico
ES2066309T3 (es) Nuevos derivados del acido p-oxibenzoico, procedimiento para su fabricacion y su aplicacion como medicamento.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees